HEPHAISTOS Awarded Best Biotech Pitch at HTID 2025

October 8, 2025

We are delighted to announce that HEPHAISTOS-Pharma has been honored with the Best Pitch nomination in the Biotech category at the 2025 HealthTech Innovation Days (HTID), organized by HealthTech For Care.

HTID is one of Europe’s premier health-innovation gatherings, bringing together life sciences companies, investors, patient associations, policy makers, and healthcare stakeholders to accelerate the translation of medical innovations into patient care.

We’re honored to be part of such a dynamic and innovative European healthtech community advancing solutions that can truly transform patient care.

This accolade affirms HEPHAISTOS-Pharma’s commitment to advancing biotech innovation with meaningful patient impact. We are energized by the conversations, feedback, and connections initiated during HTID 2025, and look forward to leveraging this momentum in the months ahead.

A huge thank you to HealthTech For Care, the jury, and the sponsors for this recognition, and congratulations to all the winners of this inspiring edition.